Search research articles
Contact Us
Filters
Showing results (21-30 of 75) with videos related to
Page
of 8
Sort By:
Scientific Reports
|
November 8, 2016
An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population
Ram K Singh, Ajit Dhadve, Asmita Sakpal, et al.
Biochemical and Biophysical Research Communications
|
April 22, 2026
p53-R248W evades doxorubicin mediated cell death through collective alteration in TOP2A and CYP1A1 genes in cancer cells
Megha Mehrotra, Priti S Shenoy, Asmita Sakpal, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
May 3, 2014
Cellular internalization and detailed toxicity analysis of protein-immobilized iron oxide nanoparticles
Purva Sanganeria, Shilpee Sachar, Sudeshna Chandra, et al.
Translational Oncology
|
August 8, 2021
Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer
Aniketh Bishnu, Megha Mehrotra, Ajit Dhadve, et al.
Cancers
|
July 27, 2022
Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway
Souvik Mukherjee, Asmita Sakpal, Megha Mehrotra, et al.
CSH Protocols
|
April 10, 2012
Split luciferase complementation assay for studying interaction of proteins x and y in cells
Ramasam Paulmurugan, Pritha Ray, Abhijit De, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
October 8, 2015
Design and Synthesis of Novel Schiff Base-Benzothiazole Hybrids as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors
Meenakshi Singh, Sudhir Kumar Singh, Bhushan Thakur, et al.
Cancers
|
February 24, 2024
Correction: Mukherjee et al. Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway. <i>Cancers</i> 2022, <i>14</i>, 3365
Souvik Mukherjee, Asmita Sakpal, Megha Mehrotra, et al.
Advances in Experimental Medicine and Biology
|
May 28, 2024
Drug-Resistant Epithelial Ovarian Cancer: Current and Future Perspectives
Megha Mehrotra, Pratham Phadte, Priti Shenoy, et al.
CSH Protocols
|
April 10, 2012
Split luciferase complementation assay for studying interaction of proteins x and y in living mice
Ramasam Paulmurugan, Pritha Ray, Abhijit De, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 75) with videos related to
Sort By:
Page
of 8
Scientific Reports
|
November 8, 2016
An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population
Ram K Singh, Ajit Dhadve, Asmita Sakpal, et al.
Biochemical and Biophysical Research Communications
|
April 22, 2026
p53-R248W evades doxorubicin mediated cell death through collective alteration in TOP2A and CYP1A1 genes in cancer cells
Megha Mehrotra, Priti S Shenoy, Asmita Sakpal, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
May 3, 2014
Cellular internalization and detailed toxicity analysis of protein-immobilized iron oxide nanoparticles
Purva Sanganeria, Shilpee Sachar, Sudeshna Chandra, et al.
Translational Oncology
|
August 8, 2021
Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer
Aniketh Bishnu, Megha Mehrotra, Ajit Dhadve, et al.
Cancers
|
July 27, 2022
Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway
Souvik Mukherjee, Asmita Sakpal, Megha Mehrotra, et al.
CSH Protocols
|
April 10, 2012
Split luciferase complementation assay for studying interaction of proteins x and y in cells
Ramasam Paulmurugan, Pritha Ray, Abhijit De, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
October 8, 2015
Design and Synthesis of Novel Schiff Base-Benzothiazole Hybrids as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors
Meenakshi Singh, Sudhir Kumar Singh, Bhushan Thakur, et al.
Cancers
|
February 24, 2024
Correction: Mukherjee et al. Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway. <i>Cancers</i> 2022, <i>14</i>, 3365
Souvik Mukherjee, Asmita Sakpal, Megha Mehrotra, et al.
Advances in Experimental Medicine and Biology
|
May 28, 2024
Drug-Resistant Epithelial Ovarian Cancer: Current and Future Perspectives
Megha Mehrotra, Pratham Phadte, Priti Shenoy, et al.
CSH Protocols
|
April 10, 2012
Split luciferase complementation assay for studying interaction of proteins x and y in living mice
Ramasam Paulmurugan, Pritha Ray, Abhijit De, et al.
Page
of 8